In the current era, scores of people are proactively looking for improved healthcare and are willing to gift themselves control over their health. Unlike never before, people understand that prevention is better than cure and are trying to keep ailments at the bay. To manage their health, people need access to affordable and clinical-grade insights to know how their lifestyle is taking a toll on their health. This is possible with at-home testing kits that indicate health hazards such as diabetes and heart diseases.

London-based healthtech startup Thriva operates with the mission to make optimal health accessible to everyone with the help of tools and actionable insights. Founded in 2015 by Hamish Grierson, Eliot Brooks and Tom Livesey, Thriva is rapidly becoming the go-to brand in the ‘proactive health’ category, an increasingly mainstream movement in which people are taking control of their own health.

Customers can understand, keep track of and improve what’s happening inside their bodies. The home testing kits offered by the startup are processed by UKAS accredited laboratories and can analyse anything from indicators of heart disease and diabetes to vitamins and minerals and hormone function. The finger-prick kit comes with proper instructions and many spare lancets to help you draw enough blood for the test. Once you do the home test, you’ll have to mail the blood sample to Thriva’s partner lab and the results will be analysed and uploaded to the platform. You will get the report and recommendations from a healthcare professional so that you bring lifestyle changes that will improve your health. In the worst case, you will be asked to consult a doctor.

The startup has recently launched new personalized health plans and high-quality supplements, which it delivers via partnerships with hospitals and other healthcare providers that wish to provide at-home testing to their patients and clients. So far the startup has processed over 115,000 test at-home blood tests in the last 4 years, with 76% of Thriva users achieving an improvement in at least one of their biomarkers between tests.

Target Global, Pembroke VCT & Guinness Asset Management are the lead investors of the revolutionary health tech startup. The startup is currently in plans to launch a corporate product aimed at companies that want to serve employees in a different way. And, those who are looking for affordable ways to offer employee health benefits.

Data source: Cruncbase, Eu-Startups & Siliconcanals.